Systematic Review

Published on 07 Apr 2020

Phase-II Trials of Pazopanib in Metastatic Neuroendocrine Neoplasia (mNEN): A Systematic Review and Meta-Analysis

in Pharmacology of Anti-Cancer Drugs

Alberto Bongiovanni
Chiara Liverani
Federica Recine
Valentina Fausti
Laura Mercatali
Alessandro Vagheggini
Chiara Spadazzi
Giacomo Miserocchi
Claudia Cocchi
Giandomenico Di Menna

Frontiers in Oncology

doi 10.3389/fonc.2020.00414

4,304 views
11 citations

Original Research

Published on 02 Apr 2020

Study of Cinobufagin as a Promising Anticancer Agent in Uveal Melanoma Through Intrinsic Apoptosis Pathway

in Pharmacology of Anti-Cancer Drugs

Leilei Zhang
Xiaolin Huang
Tao Guo
Huixue Wang
Haiyan Fan
Li Fang

Frontiers in Oncology

doi 10.3389/fonc.2020.00325

3,846 views
14 citations

Original Research

Published on 02 Apr 2020

Chamaejasmin B Decreases Malignant Characteristics of Mouse Melanoma B16F0 and B16F10 Cells

in Pharmacology of Anti-Cancer Drugs

Lingling Si
Xinyan Yan
Yan Wang
Boxue Ren
Huanhuan Ren
Yangfang Ding
Qiusheng Zheng
Defang Li
Ying Liu

Frontiers in Oncology

doi 10.3389/fonc.2020.00415

4,968 views
3 citations

Original Research

Published on 31 Mar 2020

Inhibition of microRNA-155 Reduces Neuropathic Pain During Chemotherapeutic Bortezomib via Engagement of Neuroinflammation

in Pharmacology of Anti-Cancer Drugs

Zongsheng Duan
Jian Zhang
Jing Li
Xiaochuan Pang
Hushan Wang

Frontiers in Oncology

doi 10.3389/fonc.2020.00416

4,325 views
21 citations

Original Research

Published on 27 Mar 2020

Expert Consensus on Effective Management of Chemotherapy-Induced Nausea and Vomiting: An Indian Perspective

in Pharmacology of Anti-Cancer Drugs

Ashok K. Vaid
Sudeep Gupta
Dinesh C. Doval
Shyam Agarwal
Shona Nag
Poonam Patil
Chanchal Goswami
Vikas Ostwal
Sagar Bhagat
Saiprasad Patil

Frontiers in Oncology

doi 10.3389/fonc.2020.00400

9,453 views
8 citations

Original Research

Published on 27 Mar 2020

Autophagy Induced by Proteasomal DUB Inhibitor NiPT Restricts NiPT-Mediated Cancer Cell Death

in Pharmacology of Anti-Cancer Drugs

Jinghong Chen
Xin Chen
Dacai Xu
Li Yang
Zhenjun Yang
Qianqian Yang
Ding Yan
Peiquan Zhang
Du Feng
Jinbao Liu

Frontiers in Oncology

doi 10.3389/fonc.2020.00348

5,779 views
9 citations

Systematic Review

Published on 17 Mar 2020

Genetic Polymorphisms and Platinum-Based Chemotherapy-Induced Toxicities in Patients With Lung Cancer: A Systematic Review and Meta-Analysis

in Pharmacology of Anti-Cancer Drugs

Wenhui Liu
Ying Wang
Jianquan Luo
Haiyan Yuan
Zhiying Luo

Frontiers in Oncology

doi 10.3389/fonc.2019.01573

4,725 views
9 citations

Original Research

Published on 13 Mar 2020

B7-Positive and B7-Negative Acute Myeloid Leukemias Display Distinct T Cell Maturation Profiles, Immune Checkpoint Receptor Expression, and European Leukemia Net Risk Profiles

in Pharmacology of Anti-Cancer Drugs

Ion Antohe
Angela Dǎscǎlescu
Cǎtǎlin Dǎnǎilǎ
Amalia Titieanu
Mihaela Zlei
Iuliu Ivanov
Adriana Sireteanu
Mariana Pavel
Petru Cianga

Frontiers in Oncology

doi 10.3389/fonc.2020.00264

4,954 views
12 citations

Review

Published on 12 Mar 2020

Endometrial Cancer Immune Escape Mechanisms: Let Us Learn From the Fetal–Maternal Interface

in Pharmacology of Anti-Cancer Drugs

Valentina Bruno
Giacomo Corrado
Denisa Baci
Benito Chiofalo
Maria Antonia Carosi
Livia Ronchetti
Emilio Piccione
Adriana Albini
Douglas M. Noonan
Giulia Piaggio

Frontiers in Oncology

doi 10.3389/fonc.2020.00156

8,184 views
28 citations

Original Research

Published on 10 Mar 2020

Hydrogen Sulfide Mediates Tumor Cell Resistance to Thioredoxin Inhibitor

in Pharmacology of Anti-Cancer Drugs

Zhimin Mao
Xiawen Yang
Sayumi Mizutani
Yanru Huang
Zhen Zhang
Hideyuki Shinmori
Kun Gao
Jian Yao

Frontiers in Oncology

doi 10.3389/fonc.2020.00252

3,817 views
18 citations

Clinical Trial

Published on 06 Mar 2020

Clinical and Immunological Outcomes in High-Risk Resected Melanoma Patients Receiving Peptide-Based Vaccination and Interferon Alpha, With or Without Dacarbazine Preconditioning: A Phase II Study

in Pharmacology of Anti-Cancer Drugs

Francesca Urbani
Virginia Ferraresi
Imerio Capone
Iole Macchia
Belinda Palermo
Carmen Nuzzo
Angela Torsello
Patrizio Pezzotti
Diana Giannarelli
Anna Fausta Pozzi

Frontiers in Oncology

doi 10.3389/fonc.2020.00202

4,543 views
6 citations

Case Report

Published on 05 Mar 2020

Fertility Outcomes and Sperm-DNA Parameters in Metastatic Melanoma Survivors Receiving Vemurafenib or Dabrafenib Therapy: Case Report

in Pharmacology of Anti-Cancer Drugs

Marco Ghezzi
Andrea Garolla
Sabina Magagna
Iva Šabovich
Massimiliano Berretta
Carlo Foresta
Luca De Toni

Frontiers in Oncology

doi 10.3389/fonc.2020.00232

4,923 views
5 citations

Review

Published on 05 Mar 2020

Perplexing Role of P-Glycoprotein in Tumor Microenvironment

in Pharmacology of Anti-Cancer Drugs

Kianna Robinson
Venkataswarup Tiriveedhi

Frontiers in Oncology

doi 10.3389/fonc.2020.00265

20,906 views
111 citations

Editorial

Published on 28 Feb 2020

Editorial: Therapeutic Targeting of Cancer Stem-Like Cells (CSC) – The Current State of the Art

in Pharmacology of Anti-Cancer Drugs

Cyril Corbet
Alexandre Prieur

Frontiers in Oncology

doi 10.3389/fonc.2020.00243

2,881 views
2 citations

Original Research

Published on 28 Feb 2020

Is Hydrogen Sulfide a Concern During Treatment of Lung Adenocarcinoma With Ammonium Tetrathiomolybdate?

in Pharmacology of Anti-Cancer Drugs

Xiang Li
Na Li
Li Huang
Shi Xu
Xue Zheng
Akil Hamsath
Mei Zhang
Lijun Dai
Hui Zhang
Justin Jong-Leong Wong

Frontiers in Oncology

doi 10.3389/fonc.2020.00234

8,957 views
27 citations

Original Research

Published on 25 Feb 2020

A Novel Long Non-coding RNA, MSTRG.51053.2 Regulates Cisplatin Resistance by Sponging the miR-432-5p in Non-small Cell Lung Cancer Cells

in Pharmacology of Anti-Cancer Drugs

Jie Zhang
Chuanqin Xu
Yan Gao
Yi Wang
Zongli Ding
Yueming Zhang
Wenyi Shen
Yulong Zheng
Yufeng Wan

Frontiers in Oncology

doi 10.3389/fonc.2020.00215

6,203 views
31 citations

Navigation group

Articles

Phase-II Trials of Pazopanib in Metastatic Neuroendocrine Neoplasia (mNEN): A Systematic Review and Meta-Analysis

Study of Cinobufagin as a Promising Anticancer Agent in Uveal Melanoma Through Intrinsic Apoptosis Pathway

Chamaejasmin B Decreases Malignant Characteristics of Mouse Melanoma B16F0 and B16F10 Cells

Inhibition of microRNA-155 Reduces Neuropathic Pain During Chemotherapeutic Bortezomib via Engagement of Neuroinflammation

Expert Consensus on Effective Management of Chemotherapy-Induced Nausea and Vomiting: An Indian Perspective

Autophagy Induced by Proteasomal DUB Inhibitor NiPT Restricts NiPT-Mediated Cancer Cell Death

Genetic Polymorphisms and Platinum-Based Chemotherapy-Induced Toxicities in Patients With Lung Cancer: A Systematic Review and Meta-Analysis

B7-Positive and B7-Negative Acute Myeloid Leukemias Display Distinct T Cell Maturation Profiles, Immune Checkpoint Receptor Expression, and European Leukemia Net Risk Profiles

Endometrial Cancer Immune Escape Mechanisms: Let Us Learn From the Fetal–Maternal Interface

Hydrogen Sulfide Mediates Tumor Cell Resistance to Thioredoxin Inhibitor

Clinical and Immunological Outcomes in High-Risk Resected Melanoma Patients Receiving Peptide-Based Vaccination and Interferon Alpha, With or Without Dacarbazine Preconditioning: A Phase II Study

Fertility Outcomes and Sperm-DNA Parameters in Metastatic Melanoma Survivors Receiving Vemurafenib or Dabrafenib Therapy: Case Report

Perplexing Role of P-Glycoprotein in Tumor Microenvironment

Editorial: Therapeutic Targeting of Cancer Stem-Like Cells (CSC) – The Current State of the Art

Is Hydrogen Sulfide a Concern During Treatment of Lung Adenocarcinoma With Ammonium Tetrathiomolybdate?

A Novel Long Non-coding RNA, MSTRG.51053.2 Regulates Cisplatin Resistance by Sponging the miR-432-5p in Non-small Cell Lung Cancer Cells